Patients With IPF Are at Increased Risk for Multiple Cancers

August 06, 2020 09:00pm

Researchers found that patients with idiopathic pulmonary fibrosis (IPF) are at increased risk of developing several forms of cancer compared with the general population.

FDA Clears clonoSEQ to Detect MRD in Chronic Lymphocytic Leukemia

By AJMC Staff

Real-World Analysis: Secukinumab Improves Psoriatic Arthritis Outcomes at 6 Months

By Laura Joszt

What Obstacles Are Impeding Early Diagnosis of Parkinson Disease?

By Matthew Gavidia

Hospital-Acquired Pneumonia Possibly Linked to Worse Outcomes Among Patients With Acute Heart Failure

By Maggie L. Shaw

Specialty Drug Spending After State-Mandated Out-of-Pocket Caps

August 06, 2020

Article

Despite concerns, legislation to cap out-of-pocket payments for specialty drugs has not been shown to shift costs to health plans, thereby increasing insurance premiums, according to a study published in New England Journal of Medicine.

What Is the Relationship Between Sleep, Respiratory Health Among Adolescents?

August 06, 2020

Video

The impact of impaired sleep, which is more frequent among adolescents, was associated with a greater risk of asthma and allergies among this age group, but association does not equal causation. As a result, these associations warrant greater investigation, as well as the potential effects of social determinants of health such as race and socioeconomic status, said Lakiea Wright, MD, practicing physician at Brigham and Women's Hospital in Boston and the medical director at Thermo Fisher Scientific.

ctDNA Shows Utility as Predictive Biomarker for Pembrolizumab Therapy

August 06, 2020

Article

Results from a phase 2 trial of pembrolizumab as immune checkpoint inhibition against 5 types of solid tumors show that circulating tumor DNA (ctDNA) may be used to accurately predict response to treatment.

What We're Reading: COVID-19 Disparities in Health Care Workers; Telehealth Merger Announced; CDC Warns Against Ingesting Hand Sanitizer

August 06, 2020

Article

Health care workers of color are nearly 2 times more likely than their white colleagues to test positive for coronavirus disease 2019; Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company, for $18.5 billion; the CDC has issued a warning against ingesting alcohol-based hand sanitizer in response to reports of poisonings in the United States.

Keeping Up With Guideline Recommendations: Does Patient Volume Matter in Diabetes Care?

August 06, 2020

Article

In the process of implementing a new practice guideline for treating patients with diabetes, physicians with higher patient volumes are more likely to adhere to the guideline recommendation.

Can a Community-Based Care Management Program Reduce Costs, Visits Among Medicaid Enrollees?

August 06, 2020

Podcast

Krisda H. Chaiyachati, MD, MPH, MSHP, discusses the study he co-wrote entitled “Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients.”

Telehealth Growth in May Rises Year to Year, but Drops Month to Month

August 06, 2020

Article

Robin Gelburd, JD, president of FAIR Health, discusses telehealth growth in May medical claims.

Novartis Says Tisagenlecleucel Met CRR in Early FL Data

August 05, 2020

Article

Tisagenlecleucel, sold as Kymriah by Novartis, met its primary end point of complete response rate (CRR) in an interim analysis of a phase 2 study for relapsed or refractory follicular lymphoma (FL).

Immunosuppression to Blame for Oral Microbiota Change in Children With HIV

August 05, 2020

Article

Bacterial changes in the oral cavity from immunosuppression, not HIV itself, are more likely to blame for the greater incidence of oral caries in children 6 months to 6 years, reports a study from the Department of Oral Biology at the Rutgers University School of Dental Medicine.

Continued Cough Reflex Hypersensitivity After COPD Exacerbation Predicts More Attacks

August 05, 2020

Article

Researchers found that cough reflex sensitivity is amplified during chronic obstructive pulmonary disease (COPD) exacerbation and reduces after recovery, while its persistence can help serve as a predictor for future exacerbations.